Open for submissionsPeer reviewed, fully open access, and a low article processing charge.Submit manuscript

Research ArticleOpen AccessGoogle Scholar indexed

Poly-I:C Decreases Dendritic Cell Viability Independent of PKR Activation

,
  1. 1 University of Copenhagen
Journal of Immune Based Therapies, Vaccines and Antimicrobials·Volume 01, Issue 1·Pages 1–6·Published 25 April 2012·DOI10.4236/jibtva.2012.11001
Download PDF

Abstract

Vaccination with tumor-antigen pulsed, monocyte-derived dendritic cells (DCs) has emerged as a promising strategy in cancer immunotherapy. The standard DC maturation cocktail consists of a combination of tumor necrosis factor-α (TNF-α)/interleukin (IL)-1β/IL-6 and prostaglandin E2 (PGE2) for generation of standard DCs (sDCs). In order to improve IL-12p70 production and cytotoxic T-lymphocyte (CTL) induction, a novel cocktail composed of TNF-α/IL-1β/ interferon (IFN)-α/IFN-γ and polyinosinic:polycytidylic acid (Poly-I:C) has been introduced to generate so-called α-Type-1 polarized DCs (αDC1s). We and others have previously performed a comprehensive comparison of sDCs and αDC1s. Here we demonstrate that the viability of αDC1s is lowered compared to sDCs and that DC apoptosis is mediated by Poly-I:C. We speculated that activation of protein kinase R (PKR) could mediate the observed apoptosis, but despite significantly higher PKR expression in αDC1s compared to sDCs and induction of active threonine (Thr)446 autophosphorylation of PKR in αDC1s, Poly-I:C did not influence total PKR expression or autophosporylation, indicating PKR-independent Poly-I:C-induced DC apoptosis.

KeywordsCancer ImmunotherapyDendritic CellsPoly-I:CPKR
  1. F. Sallusto and A. Lanzavecchia, “Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-Stimulating Factor plus Interleukin 4 and Downregulated by Tumor Necrosis Factor Alpha,” The Journal of Experimental Medicine, Vol. 179, No. 4, 1994, pp. 1109-1118. doi:10.1084/jem.179.4.1109
  2. I. J. de Vries, W. J. Lesterhuis, N. M. Scharenborg, L. P. Engelen, D. J. Ruiter, M. J. Gerritsen, et al., “Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients,” Clinical Cance Research, Vol. 9, 2003, p. 5091.
  3. H. Jonuleit, U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, et al., “Pro-Inflammatory Cytokines and Prostaglandins Induce Maturation of Potent Immunostimulatory Dendritic Cells under Fetal Calf Serum-Free Conditions,” European Journal of Immunology, Vol. 27, No. 12, 1997, pp. 3135-3142. doi:10.1002/eji.1830271209
  4. R. Trepiakas, A. E. Pedersen, O. Met, M. H. Hansen, A. Berntsen and I. M. Svane, “Comparison of Alpha-Type-1 Polarizing and Standard Dendritic Cell Cytokine Cocktail for Maturation of Therapeutic Monocyte-Derived Dendritic Cell Preparations from Cancer Patients,” Vaccine, Vol. 26, No. 23, 2008, pp. 2824-2832. doi:10.1016/j.vaccine.2008.03.054
  5. R. B. Mailliard, A. Wankowicz-Kalinska, Q. Cai, A. Wesa, C. M. Hilkens, M. L. Kapsenberg, et al., “Alpha- Type-1 Polarized Dendritic Cells: A Novel Immunization Tool with Optimized CTL-Inducing Activity,” Cancer Research, Vol. 64, No. 17, 2004, pp. 5934-5937. doi:10.1158/0008-5472.CAN-04-1261
  6. C. S. McAllister and C. E. Samuel, “The RNA-Activated Protein Kinase Enhances the Induction of Interferon-Beta and Apoptosis Mediated by Cytoplasmic RNA Sensors,” Journal of Biological Chemistry, Vol. 284, No. 3, 2009, pp. 1644-1651. doi:10.1074/jbc.M807888200
  7. F. Zhang, P. R. Romano, T. Nagamura-Inoue, B. Tian, T. E. Dever, M. B. Mathews, et al., “Binding of Double- Stranded RNA to Protein Kinase PKR Is Required for Dimerization and Promotes Critical Autophosphorylation Events in the Activation Loop,” Journal of Biological Chemistry, Vol. 276, No. 27, 2001, pp. 24946-24958. doi:10.1074/jbc.M102108200
  8. D. Scheuner, R. Patel, F. Wang, K. Lee, K. Kumar, J. Wu, et al., “Double-Stranded RNA-Dependent Protein Kinase Phosphorylation of the Alpha-Subunit of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis,” Journal of Biological Chemistry, Vol. 281, No. 30, 2006, pp. 21458-21468. doi:10.1074/jbc.M603784200
  9. L. Alexopoulou, A. C. Holt, R. Medzhitov and R. A. Flavell, “Recognition of Double-Stranded RNA and Activation of NF-kappa B by Toll-Like Receptor 3,” Nature, Vol. 413, No. 6857, 2001, pp. 732-738. doi:10.1038/35099560
  10. Z. Jiang, M. Zamanian-Daryoush, H. Nie, A. M. Silva, B. R. Williams and X. Li, “Poly(I-C)-Induced Toll-Like Receptor 3 (TLR3)-Mediated Activation of NFkappa B and MAP Kinase Is through an Interleukin-1 Receptor- Associated Kinase (IRAK)-Independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1- TAB2-PKR,” Journal of Biological Chemistry, Vol. 278, No. 19, 2003, pp. 16713-16719. doi:10.1074/jbc.M300562200
  11. A. E. Pedersen, M. Thorn, M. Gad, M. R. Walter, H. E. Johnsen, E. Gaarsdal, et al., “Phenotypic and Functional Characterization of Clinical Grade Dendritic Cells Generated from Patients with Advanced Breast Cancer for Therapeutic Vaccination,” Scandinavian Journal of Immunology, Vol. 61, No. 2, 2005, pp. 147-156. doi:10.1111/j.0300-9475.2005.01531.x
  12. C. A. Williams, R. A. Harry and J. D. McLeod, “Apoptotic Cells Induce Dendritic Cell-Mediated Suppression via Interferon-Gamma-Induced IDO,” Immunology, Vol. 124, No. 1, 2008, pp. 89-101. doi:10.1111/j.1365-2567.2007.02743.x
  13. M. A. Garcia, E. F. Meurs and M. Esteban, “The dsRNA Protein Kinase PKR: Virus and Cell Control,” Biochimie, Vol. 89, No. 6-7, 2007, pp. 799-811. doi:10.1016/j.biochi.2007.03.001